North Rock Partners, LLC Eli Lilly & CO Transaction History

North Rock Partners, LLC

  • $1.18 Billion
  • Q1 2024

A detailed history of North Rock Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, North Rock Partners, LLC holds 5,925 shares of LLY stock, worth $5.36 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,925
Previous 5,350 10.75%
Holding current value
$5.36 Million
Previous $3.12 Million 47.82%
% of portfolio
0.39%
Previous 0.29%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$592.2 - $792.28 $340,515 - $455,561
575 Added 10.75%
5,925 $4.61 Million
Q4 2023

Feb 08, 2024
BUY
$525.19 - $619.13 $92,433 - $108,966
176 Added 3.4%
5,350 $3.12 Million
Q3 2023

Oct 24, 2023
BUY
$434.7 - $599.3 $486,429 - $670,616
1,119 Added 27.6%
5,174 $2.78 Million
Q2 2023

Aug 02, 2023
SELL
$350.74 - $468.98 $119,602 - $159,922
-341 Reduced 7.76%
4,055 $1.9 Million
Q1 2023

May 03, 2023
SELL
$310.63 - $364.82 $244,155 - $286,748
-786 Reduced 15.17%
4,396 $1.51 Million
Q4 2022

Feb 01, 2023
BUY
$321.55 - $374.67 $335,376 - $390,780
1,043 Added 25.2%
5,182 $1.9 Million
Q3 2022

Nov 02, 2022
BUY
$296.48 - $337.87 $64,336 - $73,317
217 Added 5.53%
4,139 $1.34 Million
Q2 2022

Aug 04, 2022
BUY
$278.73 - $327.27 $74,142 - $87,053
266 Added 7.28%
3,922 $1.27 Million
Q1 2022

May 05, 2022
SELL
$234.69 - $291.66 $67,356 - $83,706
-287 Reduced 7.28%
3,656 $1.05 Million
Q4 2021

Feb 07, 2022
BUY
$224.85 - $279.04 $262,175 - $325,360
1,166 Added 41.99%
3,943 $1.09 Million
Q3 2021

Nov 12, 2021
BUY
$221.6 - $272.71 $116,118 - $142,900
524 Added 23.26%
2,777 $642,000
Q2 2021

Aug 12, 2021
BUY
$180.55 - $233.54 $121,690 - $157,405
674 Added 42.69%
2,253 $517,000
Q1 2021

May 11, 2021
BUY
$164.32 - $212.72 $16,267 - $21,059
99 Added 6.69%
1,579 $295,000
Q4 2020

Feb 08, 2021
SELL
$130.46 - $172.63 $38,224 - $50,580
-293 Reduced 16.53%
1,480 $250,000
Q3 2020

Nov 12, 2020
BUY
$146.22 - $169.13 $28,512 - $32,980
195 Added 12.36%
1,773 $262,000
Q2 2020

Aug 13, 2020
SELL
$136.42 - $164.18 $136 - $164
-1 Reduced 0.06%
1,578 $259,000
Q2 2020

Aug 11, 2020
SELL
$136.42 - $164.18 $57,842 - $69,612
-424 Reduced 21.17%
1,579 $259,000
Q1 2020

May 13, 2020
SELL
$119.05 - $147.35 $322,268 - $398,876
-2,707 Reduced 57.47%
2,003 $278,000
Q4 2019

Feb 12, 2020
SELL
$106.92 - $132.43 $636,067 - $787,826
-5,949 Reduced 55.81%
4,710 $619,000
Q4 2019

Feb 12, 2020
BUY
$106.92 - $132.43 $1.14 Million - $1.41 Million
10,659 New
10,659 $619,000

Others Institutions Holding LLY

# of Institutions
3,719
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email